Search research articles
Contact Us
Filters
Showing results (1-10 of 111) with videos related to
Page
of 12
Sort By:
Expert Opinion on Therapeutic Targets
|
March 15, 2021
CCR5 is a potential therapeutic target for cancer
Hossein Hemmatazad, Martin D Berger
Expert Opinion on Drug Safety
|
March 17, 2016
The safety of monoclonal antibodies for treatment of colorectal cancer
Martin D Berger, Heinz-Josef Lenz
British Journal of Cancer
|
July 1, 2020
Tumour budding and its clinical implications in gastrointestinal cancers
Inti Zlobec, Martin D Berger, Alessandro Lugli
Cancers
|
October 14, 2022
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
Alberto Puccini, Andreas Seeber, Martin D Berger
European Journal of Haematology
|
June 26, 2013
Pitfalls in the diagnosis of intravascular large B-cell lymphoma
Martin D Berger, Yara Banz, Thomas Pabst
Pharmaceuticals (Basel, Switzerland)
|
October 28, 2023
The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
Linh Chi Tran, Berna C Özdemir, Martin D Berger
Targeted Oncology
|
May 16, 2017
What We Know About Stage II and III Colon Cancer: It's Still Not Enough
Alberto Puccini, Martin D Berger, Wu Zhang, et al.
Histopathology
|
January 4, 2020
Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer
Bastian Dislich, Nicola Blaser, Martin D Berger, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2020
Tumour budding in solid cancers
Alessandro Lugli, Inti Zlobec, Martin D Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation
Martin D Berger, Alexander Meisel, Martin Andres, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 111) with videos related to
Sort By:
Page
of 12
Expert Opinion on Therapeutic Targets
|
March 15, 2021
CCR5 is a potential therapeutic target for cancer
Hossein Hemmatazad, Martin D Berger
Expert Opinion on Drug Safety
|
March 17, 2016
The safety of monoclonal antibodies for treatment of colorectal cancer
Martin D Berger, Heinz-Josef Lenz
British Journal of Cancer
|
July 1, 2020
Tumour budding and its clinical implications in gastrointestinal cancers
Inti Zlobec, Martin D Berger, Alessandro Lugli
Cancers
|
October 14, 2022
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
Alberto Puccini, Andreas Seeber, Martin D Berger
European Journal of Haematology
|
June 26, 2013
Pitfalls in the diagnosis of intravascular large B-cell lymphoma
Martin D Berger, Yara Banz, Thomas Pabst
Pharmaceuticals (Basel, Switzerland)
|
October 28, 2023
The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
Linh Chi Tran, Berna C Özdemir, Martin D Berger
Targeted Oncology
|
May 16, 2017
What We Know About Stage II and III Colon Cancer: It's Still Not Enough
Alberto Puccini, Martin D Berger, Wu Zhang, et al.
Histopathology
|
January 4, 2020
Preservation of Epstein-Barr virus status and mismatch repair protein status along the metastatic course of gastric cancer
Bastian Dislich, Nicola Blaser, Martin D Berger, et al.
Nature Reviews. Clinical Oncology
|
September 9, 2020
Tumour budding in solid cancers
Alessandro Lugli, Inti Zlobec, Martin D Berger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 15, 2014
Unusual case of progressive multifocal leukoencephalopathy after allogeneic hematopoietic stem-cell transplantation
Martin D Berger, Alexander Meisel, Martin Andres, et al.
Page
of 12